Key Insights EnerSys' estimated fair value is US$74.30 based on 2 Stage Free Cash Flow to Equity Current share price ...

Here we use cryogenic electron microscopy to determine the structure of TbAQP2 from Trypanosoma brucei, bound to either the substrate glycerol or to the sleeping sickness drugs, pentamidine or ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

What infrastructure is needed to realise the potential of AI in health and care? This long read considers the technical, ...

Lazzoni reports on the evolution of design thinking from product-focused to a broad problem-solving framework across various ...